Supplementary Data S1 from <i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer

crossref(2024)

引用 0|浏览0
暂无评分
摘要

Supplementary data on the comparison of anti-EGFR therapy to anti-VEGF therapy.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要